Approximately 1.4 million people in Britain are using “street cannabis” to treat chronic, medically-diagnosed health conditions, a recent poll has found. Prior to this poll, research had already shown that between 50,000 and 1.1m people in the uK use cannabis regularly
According to a new study , it’s actually the “largest ever polling sample”, and it shows how many people are purchasing cannabis outside of the law as a means of treating diagnosed, chronic health issues.
This is very interesting to note, although unexplainable. It many not be easy for people to obtain a prescription perhaps, many doctors are still closed off to the idea of doing so.
That’s why we do what we do. We help people in Canada, for example, obtain their legal medical marijuana licence to grow. We assist them with the paper work, and more importantly, we connect them with a compassionate doctors who is willing to write them the prescription they need. Everybody has different growing requirements, some people need to take their medicine in the form of oil, for example, which obviously requires a bigger prescription so one can legally grow as much as they need to do that.
This current poll from the UK was conducted by YouGov , also known as the Centre for Medicinal Cannabis (CMC) and the Cannabis Advocacy and Support Services (CPASS). They surveyed more than 10,000 people and concluded that approximately 2.8 per cent of Britain’s adult population use, again, street-available cannabis to treat medical problems.
More than half of the adults using street-bought cannabis to treat chronic health conditions said they do so on a daily basis and just under a quarter said they do so on a weekly basis.
An excerpt from the Independent:
Meanwhile, 44 per cent said they spend up to £99 a month on cannabis, while just over a fifth said they spend between £100 and £199 on cannabis every month.
Dr Daniel Couch, medical lead at the CMC, said that “robust clinical evidence” is needed to “evaluate the safety and efficacy of cannabinoid medicines”.
“For the first time we have reliable, representative data regarding the number of people in Britain using cannabis as a medicine,” Dr Couch said.
“The findings are astounding and present a national challenge.”
Ann Keen, chair of the CPASS and fellow of the Queen’s Nursing Institute, said: “[The statistics] demonstrate the vast number of patients in the UK with chronic and debilitating diagnosed conditions who feel they have no choice but to expose themselves to all the risks of accessing a medicine that works from the criminal market”.
Ms Keen added that “safe” solutions “must be explored as soon as possible”.